ABT vs ROOT · P/E 25, rev $44.33B vs P/E 14, rev $1.18B
Abbott Laboratories (ABT) versus Root Inc (ROOT) — a side-by-side from cached financials, not a winner call.
Abbott Laboratories (ABT) is a medical devices company listed on NYSE.
Root Inc (ROOT) is a insurance - property & casualty company listed on NASDAQ.
Latest reported ABT revenue for 2025-12-31 was $44.33B. Net income was $6.52B. Revenue was up 5.7% from 2024-12-31 to 2025-12-31. ABT currently screens at market cap $154.15B and trailing P/E 24.8.
Latest reported ROOT revenue for 2024-12-31 was $1.18B. Net income was $30.9M. Revenue was up 158.6% from 2023-12-31 to 2024-12-31. ROOT currently screens at market cap $767.6M and trailing P/E 14.3.
ABT currently screens at market cap $154.15B and trailing P/E 24.8. ROOT currently screens at market cap $767.6M and trailing P/E 14.3.
Not investment advice. Open the ABT and ROOT stock pages for the full models.
Not investment advice.